Cancer: Drugs

Department of Health written question – answered on 4th February 2015.

Alert me about debates like this

Photo of Lord Hunt of Kings Heath Lord Hunt of Kings Heath Shadow Spokesperson (Health), Shadow Deputy Leader of the House of Lords

To ask Her Majesty’s Government which companies refused to make appropriate adjustment to their prices to allow their drugs to stay in the Cancer Drugs Fund.

Photo of Lord Hunt of Kings Heath Lord Hunt of Kings Heath Shadow Spokesperson (Health), Shadow Deputy Leader of the House of Lords

To ask Her Majesty’s Government whether Bayer made any approach to the Cancer Drug Fund to offer to reduce their price for the use of regorafenib as a third line drug for people with gastrointestinal stromal tumours.

Photo of Earl Howe Earl Howe The Parliamentary Under-Secretary of State for Health

We cannot provide this information as information of this nature is commercial in confidence.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.